A Review of Recurrent Retinoblastoma: Children's Hospital Los Angeles Classification and Treatment Guidelines.
作者信息
Berry Jesse L, Kogachi Kaitlin, Murphree A Linn, Jubran Rima, Kim Jonathan W
出版信息
Int Ophthalmol Clin. 2019 Spring;59(2):65-75. doi: 10.1097/IIO.0000000000000269.
Abstract
摘要
相似文献
1
A Review of Recurrent Retinoblastoma: Children's Hospital Los Angeles Classification and Treatment Guidelines.复发性视网膜母细胞瘤综述：洛杉矶儿童医院分类及治疗指南
Int Ophthalmol Clin. 2019 Spring;59(2):65-75. doi: 10.1097/IIO.0000000000000269.
2
Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.全身化学减瘤治疗与初次眼球摘除术治疗晚期视网膜母细胞瘤眼的转移和眼眶复发风险。
Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26270. Epub 2016 Nov 5.
3
Current update on retinoblastoma.视网膜母细胞瘤的最新进展
Int Ophthalmol Clin. 2011 Winter;51(1):77-91. doi: 10.1097/IIO.0b013e3182010f29.
4
Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies--an analysis of impact.已发表的视网膜母细胞瘤国际分类（ICRB）定义存在不一致性——影响分析。
Ophthalmic Genet. 2009 Mar;30(1):40-4. doi: 10.1080/13816810802452168.
5
Management of advanced retinoblastoma.晚期视网膜母细胞瘤的管理
Ophthalmol Clin North Am. 2005 Mar;18(1):65-73, viii. doi: 10.1016/j.ohc.2004.09.001.
6
[Retinoblastoma].[视网膜母细胞瘤]
Rev Med Suisse. 2006 Feb 1;2(51):350-6.
7
Basic understanding of current classification and management of retinoblastoma.对视网膜母细胞瘤当前分类和管理的基本理解。
Curr Opin Ophthalmol. 2006 Jun;17(3):228-34. doi: 10.1097/01.icu.0000193079.55240.18.
8
Diagnosis, classification, and treatment of retinoblastoma.视网膜母细胞瘤的诊断、分类及治疗
Int Ophthalmol Clin. 2008 Spring;48(2):135-47. doi: 10.1097/IIO.0b013e3181693670.
9
What is the best treatment for retinoblastoma?视网膜母细胞瘤的最佳治疗方法是什么？
Am J Ophthalmol. 2004 Sep;138(3):471-3. doi: 10.1016/j.ajo.2004.05.062.
10
Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation.视网膜母细胞瘤中的玻璃体播散：临床病理分类及相关性。
Ophthalmology. 2017 Oct;124(10):1540-1547. doi: 10.1016/j.ophtha.2017.04.015. Epub 2017 May 17.
引用本文的文献
1
Survival outcomes and globe salvage rates of retinoblastoma in India - A systematic review.印度视网膜母细胞瘤的生存结果和眼球挽救率——一项系统评价
Indian J Ophthalmol. 2025 Aug 1;73(8):1116-1123. doi: 10.4103/IJO.IJO_3033_24. Epub 2025 Jul 28.
2
Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors.发展中国家视网膜母细胞瘤的动脉内美法仑化疗：真实世界的结果和预后因素
Cancers (Basel). 2025 Jun 12;17(12):1955. doi: 10.3390/cancers17121955.
3
Tumor heterogeneity in retinoblastoma: a literature review.视网膜母细胞瘤中的肿瘤异质性：文献综述
Cancer Metastasis Rev. 2025 Apr 22;44(2):46. doi: 10.1007/s10555-025-10263-5.
4
A retrospective study on adjuvant chemotherapy in retinoblastoma: validation of the new recommendation against treatment for pT2a tumors based on the 8th AJCC classification.一项关于视网膜母细胞瘤辅助化疗的回顾性研究：基于第 8 版 AJCC 分类，验证新建议反对治疗 pT2a 肿瘤的有效性。
BMC Ophthalmol. 2024 Jul 24;24(1):309. doi: 10.1186/s12886-024-03585-5.
5
Characteristics of patients with recurrent retinoblastoma: a survival analysis.复发性视网膜母细胞瘤患者的特征：生存分析。
BMC Cancer. 2024 Mar 4;24(1):287. doi: 10.1186/s12885-024-12058-3.
6
Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles.千里光碱通过直接作用和细胞外囊泡抑制耐药转移性视网膜母细胞瘤细胞的增殖和致癌性 MYCN 表达。
Biomed Pharmacother. 2023 May;161:114554. doi: 10.1016/j.biopha.2023.114554. Epub 2023 Mar 20.
7
LncRNA MEG3 inhibits retinoblastoma invasion and metastasis by inducing β-catenin degradation.长链非编码RNA MEG3通过诱导β-连环蛋白降解来抑制视网膜母细胞瘤的侵袭和转移。
Am J Cancer Res. 2022 Jul 15;12(7):3111-3127. eCollection 2022.
8
An unusual case of late recurrence of bilateral retinoblastoma.一例双侧视网膜母细胞瘤晚期复发的罕见病例。
Bone Rep. 2021 Sep 30;15:101135. doi: 10.1016/j.bonr.2021.101135. eCollection 2021 Dec.
9
The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review.动脉内化疗在难治性视网膜母细胞瘤中的作用：一项系统评价。
Clin Transl Oncol. 2021 Oct;23(10):2066-2077. doi: 10.1007/s12094-021-02610-z. Epub 2021 Apr 7.
10
Response criteria for intraocular retinoblastoma: RB-RECIST.眼内视网膜母细胞瘤的反应标准：RB-RECIST。
Pediatr Blood Cancer. 2021 May;68(5):e28964. doi: 10.1002/pbc.28964. Epub 2021 Feb 23.
本文引用的文献
1
Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.玻璃体内化疗和激光治疗视网膜母细胞瘤新出现的视网膜下播散灶
Ophthalmic Genet. 2018 Jun;39(3):353-356. doi: 10.1080/13816810.2018.1443343. Epub 2018 Mar 7.
2
Unusually very late-onset new growth of intraocular retinoblastoma: A case report and review of literature.极罕见的迟发性眼内视网膜母细胞瘤新发病例：一例报告并文献复习
Am J Ophthalmol Case Rep. 2016 Dec 28;5:130-133. doi: 10.1016/j.ajoc.2016.12.013. eCollection 2017 Apr.
3
Pars Plana Vitrectomy and Endoresection of Refractory Intraocular Retinoblastoma.玻璃体视网膜切除术及难治性眼内视网膜母细胞瘤的内界膜剥除术
Ophthalmology. 2018 Feb;125(2):320-322. doi: 10.1016/j.ophtha.2017.10.015. Epub 2017 Nov 16.
4
Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy.眼内化疗治疗视网膜母细胞瘤的眼外延伸风险。
JAMA Ophthalmol. 2017 Dec 1;135(12):1426-1429. doi: 10.1001/jamaophthalmol.2017.4600.
5
Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study.眼内化疗（美法仑）治疗视网膜母细胞瘤的房水播散：一项试点病例研究中的双眼注射技术及相关毒性
Ocul Oncol Pathol. 2017 Jul;3(2):149-155. doi: 10.1159/000453617. Epub 2016 Dec 29.
6
Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.并非所有种子都生来平等：种子分类可预测视网膜母细胞瘤的结局。
Ophthalmology. 2017 Dec;124(12):1817-1825. doi: 10.1016/j.ophtha.2017.05.034. Epub 2017 Jun 24.
7
Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.视网膜母细胞瘤玻璃体内种子云雾（3 级）：眼动脉化疗联合或不联合玻璃体内及眶周化疗的疗效比较。
Ophthalmology. 2017 Oct;124(10):1548-1555. doi: 10.1016/j.ophtha.2017.04.010. Epub 2017 May 22.
8
Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation.视网膜母细胞瘤中的玻璃体播散：临床病理分类及相关性。
Ophthalmology. 2017 Oct;124(10):1540-1547. doi: 10.1016/j.ophtha.2017.04.015. Epub 2017 May 17.
9
Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.玻璃体内化疗在视网膜母细胞瘤玻璃体疾病治疗中的应用
Eur J Ophthalmol. 2017 Jun 26;27(4):423-427. doi: 10.5301/ejo.5000921. Epub 2017 Jan 2.
10
Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.既往接受化疗后，对大量持续性或复发性视网膜母细胞瘤视网膜下种植灶进行二期和三期动脉内化疗：30只眼的长期肿瘤控制和眼球挽救情况
J AAPOS. 2016 Aug;20(4):337-42. doi: 10.1016/j.jaapos.2016.05.009. Epub 2016 Jun 18.
Zotero 插件